tiprankstipranks
Trending News
More News >
Edwards Lifesciences (DE:EWL)
XETRA:EWL
Germany Market

Edwards Lifesciences (EWL) Ratios

Compare
3 Followers

Edwards Lifesciences Ratios

DE:EWL's free cash flow for Q4 2024 was $0.79. For the 2024 fiscal year, DE:EWL's free cash flow was decreased by $ and operating cash flow was $0.32. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.18 3.38 3.03 3.08 3.46
Quick Ratio
3.45 2.40 2.17 2.38 2.56
Cash Ratio
2.02 0.96 0.75 0.84 1.32
Solvency Ratio
1.44 0.59 0.68 0.62 0.36
Operating Cash Flow Ratio
0.36 0.75 1.19 1.68 1.18
Short-Term Operating Cash Flow Coverage
0.00 0.00 47.77 67.93 38.76
Net Current Asset Value
$ 3.29B$ 1.39B$ 610.00M$ 514.00M$ 428.20M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.08 0.08 0.10
Debt-to-Equity Ratio
0.07 0.10 0.12 0.12 0.15
Debt-to-Capital Ratio
0.07 0.09 0.11 0.11 0.13
Long-Term Debt-to-Capital Ratio
0.06 0.08 0.09 0.09 0.12
Financial Leverage Ratio
1.31 1.41 1.43 1.46 1.58
Debt Service Coverage Ratio
0.00 89.14 38.36 38.52 22.81
Interest Coverage Ratio
0.00 87.16 91.07 73.29 103.06
Debt to Market Cap
0.01 0.01 0.01 <0.01 0.01
Interest Debt Per Share
1.19 1.17 1.15 1.14 1.14
Net Debt to EBITDA
-1.32 -0.25 -0.04 -0.09 -0.45
Profitability Margins
Gross Profit Margin
79.18%77.02%79.93%76.13%75.36%
EBIT Margin
29.73%26.91%33.32%33.00%21.41%
EBITDA Margin
31.99%29.44%36.42%36.12%24.49%
Operating Profit Margin
26.75%25.55%32.49%25.77%37.12%
Pretax Profit Margin
29.13%26.61%32.84%32.53%20.90%
Net Profit Margin
75.48%23.35%28.28%28.73%18.77%
Continuous Operations Profit Margin
25.95%23.30%28.28%28.73%18.77%
Net Income Per EBT
259.12%87.75%86.11%88.31%89.82%
EBT Per EBIT
108.90%104.17%101.08%126.21%56.29%
Return on Assets (ROA)
32.02%14.98%18.35%17.68%11.38%
Return on Equity (ROE)
49.04%21.09%26.21%25.76%18.00%
Return on Capital Employed (ROCE)
12.83%18.78%24.05%18.05%25.67%
Return on Invested Capital (ROIC)
11.40%16.40%20.57%15.83%22.86%
Return on Tangible Assets
41.38%18.26%22.24%21.44%14.36%
Earnings Yield
9.65%3.03%3.30%1.86%1.45%
Efficiency Ratios
Receivables Turnover
7.61 7.25 7.70 7.87 7.28
Payables Turnover
5.84 6.85 5.35 6.11 5.50
Inventory Turnover
1.06 1.18 1.23 1.72 1.35
Fixed Asset Turnover
3.10 3.26 3.12 3.19 2.95
Asset Turnover
0.42 0.64 0.65 0.62 0.61
Working Capital Turnover Ratio
1.16 2.44 2.55 2.41 2.05
Cash Conversion Cycle
329.43 306.08 274.98 199.00 254.79
Days of Sales Outstanding
47.93 50.34 47.41 46.38 50.16
Days of Inventory Outstanding
343.98 309.03 295.78 212.38 271.00
Days of Payables Outstanding
62.48 53.28 68.21 59.77 66.37
Operating Cycle
391.92 359.36 343.19 258.76 321.16
Cash Flow Ratios
Operating Cash Flow Per Share
0.92 1.48 1.97 2.78 1.69
Free Cash Flow Per Share
0.49 1.04 1.54 2.25 1.04
CapEx Per Share
0.43 0.44 0.43 0.53 0.65
Free Cash Flow to Operating Cash Flow
0.53 0.70 0.78 0.81 0.61
Dividend Paid and CapEx Coverage Ratio
2.15 3.36 4.60 5.25 2.59
Capital Expenditure Coverage Ratio
2.15 3.36 4.60 5.25 2.59
Operating Cash Flow Coverage Ratio
0.77 1.29 1.76 2.51 1.52
Operating Cash Flow to Sales Ratio
0.10 0.15 0.23 0.33 0.24
Free Cash Flow Yield
0.67%1.36%2.06%1.74%1.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.36 32.99 30.35 53.72 68.98
Price-to-Sales (P/S) Ratio
7.82 7.70 8.58 15.43 12.95
Price-to-Book (P/B) Ratio
4.33 6.96 7.95 13.84 12.42
Price-to-Free Cash Flow (P/FCF) Ratio
149.39 73.49 48.44 57.58 87.79
Price-to-Operating Cash Flow Ratio
79.90 51.64 37.91 46.62 53.87
Price-to-Earnings Growth (PEG) Ratio
24.11 -5.41 14.63 0.65 -3.22
Price-to-Fair Value
4.33 6.96 7.95 13.84 12.42
Enterprise Value Multiple
23.12 25.92 23.52 42.63 52.42
Enterprise Value
40.96B 45.81B 46.11B 80.58B 56.31B
EV to EBITDA
23.12 25.92 23.52 42.63 52.42
EV to Sales
7.40 7.63 8.57 15.40 12.84
EV to Free Cash Flow
141.30 72.77 48.36 57.46 87.03
EV to Operating Cash Flow
75.54 51.14 37.85 46.52 53.41
Tangible Book Value Per Share
12.11 8.30 7.04 6.97 4.93
Shareholders’ Equity Per Share
17.04 10.96 9.38 9.36 7.35
Tax and Other Ratios
Effective Tax Rate
0.11 0.12 0.14 0.12 0.10
Revenue Per Share
9.44 9.90 8.70 8.39 7.05
Net Income Per Share
7.12 2.31 2.46 2.41 1.32
Tax Burden
2.59 0.88 0.86 0.88 0.90
Interest Burden
0.98 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.19 0.18 0.18 0.17 0.17
SG&A to Revenue
0.00 0.30 0.29 0.29 0.00
Stock-Based Compensation to Revenue
0.03 0.02 0.02 0.02 0.02
Income Quality
0.13 0.64 0.80 1.15 1.28
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis